Provided by Tiger Trade Technology Pte. Ltd.

iBio

1.36
-0.0400-2.86%
Post-market: 1.390.0291+2.14%19:30 EDT
Volume:521.25K
Turnover:712.14K
Market Cap:67.56M
PE:-2.43
High:1.42
Open:1.42
Low:1.34
Close:1.40
52wk High:3.82
52wk Low:0.7708
Shares:49.68M
Float Shares:34.88M
Volume Ratio:1.11
T/O Rate:1.49%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.5600
EPS(LYR):-1.7504
ROE:-65.70%
ROA:-30.80%
PB:0.79
PE(LYR):-0.78

Loading ...

Ibio Inc : B. Riley Initiates Coverage With Buy Rating; Target Price $6

THOMSON REUTERS
·
Jun 05

B. Riley Initiates iBio at Buy With $6 Price Target

MT Newswires Live
·
Jun 05

U.S. RESEARCH ROUNDUP-Chipotle Mexican Grill, Honeywell, Tesla

Reuters
·
Jun 05

iBio executives present at Jefferies Global Healthcare Conference

Reuters
·
Jun 03

iBio to Participate in Upcoming Healthcare Investor Conferences

GlobeNewswire
·
Jun 03

iBio doses first patient in Phase 1 trial of obesity drug candidate IBIO-600

Reuters
·
Jun 02

Ibio Becomes a Clinical-Stage Company With First Participant Dosed in Phase 1 Clinical Trial of Ibio-600 in Adults With Obesity

THOMSON REUTERS
·
Jun 02

IBIO-600 First-in-Human Obesity Trial Puts iBio on Investors’ Radar

TIPRANKS
·
May 30

LifeSci Capital Remains a Buy on Ibio (IBIO)

TIPRANKS
·
May 16

iBio files Form 3 as director Elizabeth Stoner reports no beneficial ownership

Reuters
·
May 15

Oppenheimer Reaffirms Their Buy Rating on Ibio (IBIO)

TIPRANKS
·
May 14

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Ibio (IBIO), MaxCyte (MXCT) and Atea Pharmaceuticals (AVIR)

TIPRANKS
·
May 13

BRIEF-Ibio Reports Q3 Fiscal Year 2026 Financial Results And Provides Corporate Update

Reuters
·
May 13

iBio reports Q3 EPS (7c), consensus (6c)

TIPRANKS
·
May 13

iBio Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
May 13

iBio Q3 EPS $(0.07) Misses $(0.06) Estimate

Benzinga Earnings
·
May 13

iBio wins Australian clearance to start Phase 1 trial of obesity drug IBIO-600

Reuters
·
May 13

iBio FY26 Q3 net loss widens to $7.73 million; operating loss widens to $8.37 million

Reuters
·
May 13

Ibio Inc - Reports No Revenue for Q3 Ended March 31, 2026

THOMSON REUTERS
·
May 13

Ibio Inc: Qtrly Loss per Share $-0.07

THOMSON REUTERS
·
May 13